BLTI Insider Trading Activity and SEC Form 4 Filings
BLTI insider trading summary
No open-market insider purchases or sales of Biolase, Inc (BLTI) have been reported on SEC Form 4 in the past 12 months.
Latest BLTI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 14, 2012 | Alexander K. Arrow | Director | Buy | $2K (1,363 @ $1.71) |
| Aug 14, 2012 | Alexander K. Arrow | Director | Buy | $2K (1,100 @ $1.72) |
| Aug 14, 2012 | Alexander K. Arrow | Director | Buy | $1K (723 @ $1.68) |
| Aug 14, 2012 | Alexander K. Arrow | Director | Buy | $676 (400 @ $1.69) |
| Aug 14, 2012 | Alexander K. Arrow | Director | Buy | $2K (1,237 @ $1.73) |
| Aug 14, 2012 | Alexander K. Arrow | Director | Buy | $641 (377 @ $1.70) |
| Aug 14, 2012 | Alexander K. Arrow | Director | Buy | $8K (4,800 @ $1.67) |
| Aug 13, 2012 | Alexander K. Arrow | Director | Buy | $16K (9,000 @ $1.80) |
| Aug 13, 2012 | Alexander K. Arrow | Director | Buy | $522 (300 @ $1.74) |
| Aug 13, 2012 | Alexander K. Arrow | Director | Buy | $3K (1,600 @ $1.75) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.